Evidence map›Paper›PMID 39228898›Full record

ArticleAfrican journal of laboratory medicine2024

Lessons learnt from assessing and improving accuracy and positive predictive value of the national HIV testing algorithm in Nigeria.

Augustine O Mpamugo, Nnaemeka C Iriemenam, Adebobola Bashorun, Olumide O Okunoye, Orji O Bassey, Edewede Onokevbagbe, Tapdiyel Jelpe, Matthias A Alagi, Chidozie Meribe, Rose E Aguolu and 12 more

Abstract read
In one paragraph

Article in African journal of laboratory medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Augustine O MpamugoCenter for International Health, Education and Biosecurity, Maryland Global Initiatives Corporation, University of Maryland, Baltimore (UMB), Abuja, Nigeria.ORCID https://orcid.org/0000-0003-1803-4690
Nnaemeka C IriemenamDivision of Global HIV and TB, United States Centers for Disease Control and Prevention, Abuja, Nigeria.ORCID https://orcid.org/0000-0003-2187-8894
Adebobola BashorunNational AIDS, Viral Hepatitis, and STIs Control Programme, Federal Ministry of Health, Abuja, Nigeria.ORCID https://orcid.org/0000-0002-3791-1313
Olumide O OkunoyeDivision of Global HIV and TB, United States Centers for Disease Control and Prevention, Abuja, Nigeria.ORCID https://orcid.org/0000-0003-0832-5240
Orji O BasseyDivision of Global HIV and TB, United States Centers for Disease Control and Prevention, Abuja, Nigeria.ORCID https://orcid.org/0000-0002-5770-1989
Edewede OnokevbagbeCenter for International Health, Education and Biosecurity, Maryland Global Initiatives Corporation, University of Maryland, Baltimore (UMB), Abuja, Nigeria.ORCID https://orcid.org/0000-0003-3242-1830
Tapdiyel JelpeDivision of Global HIV and TB, United States Centers for Disease Control and Prevention, Abuja, Nigeria.ORCID https://orcid.org/0000-0002-4756-6509
Matthias A AlagiDivision of Global HIV and TB, United States Centers for Disease Control and Prevention, Abuja, Nigeria.ORCID https://orcid.org/0000-0002-6188-3527
Chidozie MeribeDivision of Global HIV and TB, United States Centers for Disease Control and Prevention, Abuja, Nigeria.ORCID https://orcid.org/0000-0002-5878-486X
Rose E AguoluDepartment of Research Monitoring and Evaluation, National Agency for the Control of AIDS, Abuja, Nigeria.ORCID https://orcid.org/0000-0002-5772-0063
Charles E NzeluDepartment of Planning, Research and Statistics, Federal Ministry of Health, Abuja, Nigeria.ORCID https://orcid.org/0000-0003-3464-865X
Segun BelloCenter for International Health, Education and Biosecurity, Maryland Global Initiatives Corporation, University of Maryland, Baltimore (UMB), Abuja, Nigeria.ORCID https://orcid.org/0000-0003-0665-223X
Babatunde EzraCenter for International Health, Education and Biosecurity, Maryland Global Initiatives Corporation, University of Maryland, Baltimore (UMB), Abuja, Nigeria.ORCID https://orcid.org/0009-0006-8125-090X
Christine A ObiohaCenter for International Health, Education and Biosecurity, Maryland Global Initiatives Corporation, University of Maryland, Baltimore (UMB), Abuja, Nigeria.ORCID https://orcid.org/0000-0002-7043-4651
Baffa S IbrahimCenter for International Health, Education and Biosecurity, Maryland Global Initiatives Corporation, University of Maryland, Baltimore (UMB), Abuja, Nigeria.ORCID https://orcid.org/0000-0001-6997-0943
Oluwasanmi AdedokunCenter for International Health, Education and Biosecurity, Maryland Global Initiatives Corporation, University of Maryland, Baltimore (UMB), Abuja, Nigeria.ORCID https://orcid.org/0000-0002-4678-9735
Akudo IkpeazuNational AIDS, Viral Hepatitis, and STIs Control Programme, Federal Ministry of Health, Abuja, Nigeria.ORCID https://orcid.org/0000-0002-0654-2201
Chikwe IhekweazuNigeria Centers for Disease Control, Abuja, Nigeria.ORCID https://orcid.org/0000-0003-0659-0833
Talishiea CroxtonInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States.ORCID https://orcid.org/0000-0003-3095-3817
Sylvia B AdebajoInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States.ORCID https://orcid.org/0000-0002-5933-8044
McPaul I J OkoyeDivision of Global HIV and TB, United States Centers for Disease Control and Prevention, Abuja, Nigeria.ORCID https://orcid.org/0000-0001-8745-8441
Alash'le AbimikuInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States.ORCID https://orcid.org/0000-0003-2213-0204

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: HIV testing remains an entry point into HIV care and treatment services. In 2007, Nigeria adopted and implemented a two-test rapid HIV testing algorithm of three HIV rapid test kits, following the sequence: Alere Determine (first test), Unigold Intervention: A two-phased evaluation method was employed, including abstraction and analysis of retrospective HIV testing data from January 2017 to December 2019 from 24 selected sites supported by the United States President's Emergency Plan for AIDS Relief programme. A prospective evaluation of HIV testing was done among 2895 consecutively enrolled and consented adults, aged 15-64 years, accessing HIV testing services from three selected sites per state across the six geopolitical zones of Nigeria between July 2020 and September 2020. The prospective evaluation was performed both in the field and at the National Reference Laboratory under controlled laboratory conditions. Stakeholder engagements, strategic selection and training of study personnel, and integrated supportive supervision were employed to assure the quality of evaluation procedures and outcomes. Lessons learnt: The algorithm showed higher sensitivity and specificity in the National Reference Laboratory compared with the field. The approaches to quality assurance were integral to the high-quality study outcomes. Recommendations: We recommend comparison of testing algorithms under evaluation against a gold standard. What this study adds: This study provides context-specific considerations in using World Health Organization recommendations to evaluate the Nigerian national HIV rapid testing algorithm.

Indexed as

HIV/AIDSHIV rapid testlessons learntNigeriatesting algorithm

Identifiers

PMID39228898
PMCPMC11369579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.